Development of a Concise Synthesis of (+)-lngenol.

The complex diterpenoid (+)-ingenol possesses a uniquely challenging scaffold and constitutes the core of a recently approved anti-cancer drug. This full account details the development of a short synthesis of 1 that takes place in two separate phases (cyclase and oxidase) as loosely modeled after t...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of the American Chemical Society Vol. 136; no. 15; pp. 5799 - 5811
Autores principales: McKerrall, Steven J., Jørgensen, Lars, Kuttruff, Christian A., Ungeheuer, Felix, Baran, Phil S.
Formato: Artículo
Publicado: American Chemical Society 4/16/2014
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=hlh&AN=96121687&site=ehost-live
header:
  @attributes:
    shortDbName: hlh
    uiTerm: 96121687
    longDbName: Humanities International Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00027863
        ACS
      jtl: Journal of the American Chemical Society
      issn: 00027863
      maglogo: N
    pubinfo:
      dt: 4/16/2014
      vid: 136
      iid: 15
      pid: 997
      pub: American Chemical Society
    artinfo:
      ui:
        96121687
        10.1021/ja501881p
      ppf: 5799
      ppct: 12
      formats:
      tig:
        atl: Development of a Concise Synthesis of (+)-lngenol.
      aug:
        au:
          McKerrall, Steven J.
          Jørgensen, Lars
          Kuttruff, Christian A.
          Ungeheuer, Felix
          Baran, Phil S.
        affil: Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
      su:
        Diterpenes
        Cyclases
        Density functional theory
        Pinacol rearrangement
        Pinacols
      sug:
        subj:
          Diterpenes
          Cyclases
          Density functional theory
          Pinacol rearrangement
          Pinacols
      ab: The complex diterpenoid (+)-ingenol possesses a uniquely challenging scaffold and constitutes the core of a recently approved anti-cancer drug. This full account details the development of a short synthesis of 1 that takes place in two separate phases (cyclase and oxidase) as loosely modeled after terpene biosynthesis. Initial model studies establishing the viability of a Pauson--Khand approach to building up the carbon framework are recounted. Extensive studies that led to the development of a 7-step cyclase phase to transform (+)-3-carene into a suitable tigliane-type core are also presented. A variety of competitive pinacol rearrangements and cyclization reactions were overcome to develop a 7-step oxidase phase producing (+)-ingenol. The pivotal pinacol rearrangement is further examined through DFT calculations, and implications for the biosynthesis of (+)-ingenol are discussed.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: Y
      dt:
        @attributes:
          year: 2014
    holdings:
      @attributes:
        islocal: N